Maximizing Oligonucleotide Therapeutic Development: How They Work Blog Maximizing Oligonucleotide Therapeutic Development: How They Work This is the first of three blog posts discussing best practices for developing oligonucleotides. Interest…Certara2021年5月7日
Planning a Health Canada PRCI Compliant Submission Blog Planning a Health Canada PRCI Compliant Submission How to set yourself up for a successful Health Canada PRCI submissionCertara2021年4月26日
Simcyp Simulator Impacts 80+ Novel Drugs Blog Simcyp Simulator Impacts 80+ Novel Drugs 250 Label claims using PBPK without the need for additional clinical studies “Clinical Studies and…Certara2021年3月17日
The Importance of Continuity of Operations Plans for Gene Therapy Manufacturers Blog The Importance of Continuity of Operations Plans for Gene Therapy Manufacturers By: James Zoshak The COVID-19 pandemic has added increased risk and uncertainty to gene therapy…Certara2021年2月22日
Getting Gene Therapies to Patients Blog 遺伝子治療を患者へ届けるために This blog discusses the challenges that drug developers face in getting patients access to cell…Certara2021年2月16日
Why Consistency in Patient Safety Narratives is Crucial Blog なぜ患者の安全性に関する説明には一貫性が必要なのか “You would not be able to tell 40 different writers were authoring these. It looked…Certara2021年2月9日
8 Tips for Successfully Developing Oligonucleotide Therapies Blog オリゴヌクレオチド治療薬の開発を成功させるための8つのヒント By Eva Gil Berglund and Nathalie H Gosselin Oligonucleotide therapeutics are a validated class of…Certara2021年2月1日
Dose Optimization using the Gene Therapy Virtual Twin Platform Blog Gene Therapy Virtual Twin Platformを活用した投与量の最適化 This blog explains how using the Gene Therapy Virtual Twin™ Platform can help optimize dosing…Certara2021年1月22日
Be Honest, Be Reliable, Be Human: Insights from a Global Drug Development Expert Blog 正直であれ、確実であれ、人間的であれ:グローバル医薬品開発エキスパートからのアドバイス One of the most exciting things about working in the pharmaceutical industry is the ability…Certara2020年12月16日
Regulatory submissions and transactions with Health Canada Blog Regulatory submissions and transactions with Health Canada By Robert Labriola We’ve seen recent trends and activity with regards to pharmaceutical regulatory submissions…Certara2020年11月19日